Liquid Biopsy in Prostate Cancer: Circulating Tumor Cells and Beyond
Authors:
- 1 September 2018
- book chapter
- Published by Springer Nature
- Vol. 175, 87-104
Abstract
Prostate cancer is a common malignancy impacting countless men without curative options in the advanced state. Numerous therapies have been introduced in recent years improving survival and symptom control, yet optimal methods for predicting or monitoring response have not been developed. In the era of precision medicine, characterization of individual cancers is necessary to inform treatment decisions. Liquid biopsies, through evaluation of various blood-based analytes, provide a method of patient evaluation with potential applications in virtually all disease states. In this review, we will describe current approaches with a particular focus on demonstrated clinical utility in the evaluation and management of prostate cancer.Keywords
This publication has 90 references indexed in Scilit:
- Cancer statistics, 2016CA: A Cancer Journal for Clinicians, 2016
- Systematic Review and Meta-analysis of Factors Determining Change to Radical Treatment in Active Surveillance for Localized Prostate CancerEuropean Urology, 2015
- The complex seeds of metastasisNature, 2015
- Changes in prostate-specific antigen, markers of bone metabolism and bone scans after treatment with radium-223Scandinavian Journal of Urology, 2014
- The utility of prostate‐specific antigen in the management of advanced prostate cancerBJU International, 2013
- Initial management of prostate‐specific antigen‐detected, low‐risk prostate cancer and the risk of death from prostate cancerBJU International, 2013
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate CancerNew England Journal of Medicine, 2010
- Cancer Metastasis: Building a FrameworkCell, 2006
- Tumor metastasis: mechanistic insights and clinical challengesNature Medicine, 2006
- Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant DiseasesClinical Cancer Research, 2004